论文部分内容阅读
目的探讨针对早期2型糖尿病肾病患者应用匹伐他汀钙对其尿白蛋白排泄率的影响。方法早期2型糖尿病肾病患者96例,随机分为实验组与对照组,各48例,对照组仅给予临床常规治疗,实验组在常规治疗的同时应用匹伐他汀钙,比较两组样本的尿白蛋白排泄率。结果实验组患者治疗后尿白蛋白排泄率为(46.8±12.9)mg/g,显著低于对照组(86.4±34.2)mg/g,差异具有统计学意义(P<0.05)。结论针对早期2型糖尿病肾病患者采用匹伐他汀钙能显著改善尿白蛋白排泄率。
Objective To investigate the effect of pitavastatin calcium on urinary albumin excretion rate in patients with early type 2 diabetic nephropathy. Methods 96 patients with early stage type 2 diabetic nephropathy were randomly divided into experimental group and control group, 48 cases in each group. The control group was given only routine clinical treatment. The experimental group was treated with pitavastatin calcium while routine treatment, Albumin excretion rate. Results The urinary albumin excretion rate of the experimental group was (46.8 ± 12.9) mg / g, which was significantly lower than that of the control group (86.4 ± 34.2) mg / g. The difference was statistically significant (P <0.05). Conclusion The use of pitavastatin calcium in patients with early type 2 diabetic nephropathy can significantly improve urinary albumin excretion rate.